Ray G Pillai (Ray Pillai)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Top Venues

Science advances

Cancer research

Cancer discovery

bioRxiv : the preprint server for biology

This page only lists publications with an associated author ORCID identifier.

Publications

Ray G Pillai, Sarah E LeBoeuf, Yuan Hao, Connie New, Jenna L E Blum, Ali Rashidfarrokhi, Shih Ming Huang, Christian Bahamon, Warren L Wu, Burcu Karadal-Ferrena, Alberto Herrera, Ellie N Ivanova, Michael Cross, Jozef P Bossowski, Hongyu Ding, Makiko Hayashi, Sahith Rajalingam, Triantafyllia Karakousi, Volkan I Sayin, Kamal M Khanna, Kwok-Kin Wong, Robert Wild, Aristotelis Tsirigos, John T Poirier, Charles M Rudin, Shawn M Davidson, Sergei B Koralov, Thales Papagiannakopoulos
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. Science advances 10 (13) (2024)
Ray G Pillai, Thales Papagiannakopoulos
DON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism. Cancer research 84 (3) (2024)
Jun-Chieh J Tsay, Fares Darawshy, Chan Wang, Benjamin Kwok, Kendrew K Wong, Benjamin G Wu, Imran Sulaiman, Hua Zhou, Bradley Isaacs, Matthias C Kugler, Elizabeth Sanchez, Alexander Bain, Yonghua Li, Rosemary Schluger, Alena Lukovnikova, Destiny Collazo, Yaa Kyeremateng, Ray G Pillai, Miao Chang, Qingsheng Li, Rami S Vanguri, Anton Sebastian Becker, William H Moore, George D Thurston, Terry Gordon, Andre L Moreira, Chandra M Goparaju, Daniel H Sterman, Aristotelis Tsirigos, Huilin Li, Leopoldo N Segal, Harvey I Pass
Lung microbial and host genomic signatures as predictors of prognosis in early-stage adenocarcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Ray G Pillai, Sarah E LeBoeuf, Yuan Hao, Connie New, Jenna L E Blum, Ali Rashidfarrokhi, Shih Ming Huang, Christian Bahamon, Warren L Wu, Burcu Karadal-Ferrena, Alberto Herrera, Ellie N Ivanova, Michael Cross, Jozef P Bossowski, Hongyu Ding, Makiko Hayashi, Sahith Rajalingam, Triantafyllia Karakousi, Volkan I Sayin, Kamal M Khanna, Kwok-Kin Wong, Robert Wild, Aristotelis Tsirigos, John T Poirier, Charles M Rudin, Shawn M Davidson, Sergei B Koralov, Thales Papagiannakopoulos
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. Science advances 10 (13) (2024)
Ray G Pillai, Sarah E LeBoeuf, Yuan Hao, Connie New, Jenna L E Blum, Ali Rashidfarrokhi, Shih Ming Huang, Christian Bahamon, Warren L Wu, Burcu Karadal-Ferrena, Alberto Herrera, Ellie N Ivanova, Michael Cross, Jozef P Bossowski, Hongyu Ding, Makiko Hayashi, Sahith Rajalingam, Triantafyllia Karakousi, Volkan I Sayin, Kamal M Khanna, Kwok-Kin Wong, Robert Wild, Aristotelis Tsirigos, John T Poirier, Charles M Rudin, Shawn M Davidson, Sergei B Koralov, Thales Papagiannakopoulos
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. Science advances 10 (13) (2024)
Ray G Pillai, Sarah E LeBoeuf, Yuan Hao, Connie New, Jenna L E Blum, Ali Rashidfarrokhi, Shih Ming Huang, Christian Bahamon, Warren L Wu, Burcu Karadal-Ferrena, Alberto Herrera, Ellie N Ivanova, Michael Cross, Jozef P Bossowski, Hongyu Ding, Makiko Hayashi, Sahith Rajalingam, Triantafyllia Karakousi, Volkan I Sayin, Kamal M Khanna, Kwok-Kin Wong, Robert Wild, Aristotelis Tsirigos, John T Poirier, Charles M Rudin, Shawn M Davidson, Sergei B Koralov, Thales Papagiannakopoulos
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. Science advances 10 (13) (2024)
Ray G Pillai, Sarah E LeBoeuf, Yuan Hao, Connie New, Jenna L E Blum, Ali Rashidfarrokhi, Shih Ming Huang, Christian Bahamon, Warren L Wu, Burcu Karadal-Ferrena, Alberto Herrera, Ellie N Ivanova, Michael Cross, Jozef P Bossowski, Hongyu Ding, Makiko Hayashi, Sahith Rajalingam, Triantafyllia Karakousi, Volkan I Sayin, Kamal M Khanna, Kwok-Kin Wong, Robert Wild, Aristotelis Tsirigos, John T Poirier, Charles M Rudin, Shawn M Davidson, Sergei B Koralov, Thales Papagiannakopoulos
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. Science advances 10 (13) (2024)
Ray G Pillai, Thales Papagiannakopoulos
DON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism. Cancer research 84 (3) (2024)
Ray G Pillai, Thales Papagiannakopoulos
DON of Hope: Starving Pancreatic Cancer by Glutamine Antagonism. Cancer research (2023)
Ray G Pillai, Sarah E Leboeuf, Yuan Hao, Connie New, Jenna L E Blum, Ali Rashidfarrokhi, Shih Ming Huang, Christian Bahamon, Warren L Wu, Burcu Karadal-Ferrena, Alberto Herrera, Ellie N Ivanova, Michael Cross, Jozef P Bossowski, Hongyu Ding, Makiko Hayashi, Sahith Rajalingam, Triantafyllia Karakousi, Volkan I Sayin, Kamal M Khanna, Kwok-Kin Wong, Robert Wild, Aristotelis Tsirigos, John T Poirier, Charles M Rudin, Shawn M Davidson, Sergei B Koralov, Thales Papagiannakopoulos
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer. bioRxiv : the preprint server for biology (2023)
Ali Rashidfarrokhi, Ray G Pillai, Yuan Hao, Warren L Wu, Burcu Karadal-Ferrena, Sofia G Dimitriadoy, Michael Cross, Anna H Yeaton, Shih Ming Huang, Arjun J Bhutkar, Alberto Herrera, Sahith Rajalingam, Makiko Hayashi, Kuan-Lin Huang, Eric Bartnicki, Anastasia-Maria Zavitsanou, Corrin A Wohlhieter, Sarah E Leboeuf, Ting Chen, Cynthia Loomis, Valeria Mezzano, Ruth Kulicke, Fred P Davis, Nicolas Stransky, Gromoslaw A Smolen, Charles M Rudin, Andre L Moreira, Kamal M Khanna, Harvey I Pass, Kwok-Kin Wong, Shohei Koide, Aristotelis Tsirigos, Sergei B Koralov, Thales Papagiannakopoulos
Tumor-intrinsic LKB1-LIF signaling axis establishes a myeloid niche to promote immune evasion and tumor growth. bioRxiv : the preprint server for biology (2023)
Ray G Pillai, Makiko Hayashi, Anastasia-Maria Zavitsanou, Thales Papagiannakopoulos
NRF2: KEAPing Tumors Protected. Cancer discovery 12 (3) (2022)
Hongyu Ding, Zihong Chen, Katherine Wu, Shih Ming Huang, Warren L Wu, Sarah E Leboeuf, Ray G Pillai, Joshua D Rabinowitz, Thales Papagiannakopoulos
Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition. Science advances 7 (47) (2021)
Jun-Chieh J Tsay, Benjamin G Wu, Imran Sulaiman, Katherine Gershner, Rosemary Schluger, Yonghua Li, Ting-An Yie, Peter Meyn, Evan Olsen, Luisannay Perez, Brendan Franca, Joseph Carpenito, Tadasu Iizumi, Mariam El-Ashmawy, Michelle Badri, James T Morton, Nan Shen, Linchen He, Gaetane Michaud, Samaan Rafeq, Jamie L Bessich, Robert L Smith, Harald Sauthoff, Kevin Felner, Ray G Pillai, Anastasia-Maria Zavitsanou, Sergei B Koralov, Valeria Mezzano, Cynthia A Loomis, Andre L Moreira, William Moore, Aristotelis Tsirigos, Adriana Heguy, William N Rom, Daniel H Sterman, Harvey I Pass, Jose C Clemente, Huilin Li, Richard Bonneau, Kwok-Kin Wong, Thales Papagiannakopoulos, Leopoldo N Segal
Lower Airway Dysbiosis Affects Lung Cancer Progression. Cancer discovery 11 (2) (2020)